Endologix (ELGX) Tops Q3 EPS by 1c; Guides In-line
More News related to ELGX
- Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR
- Endologix to Present at Three Upcoming Conferences
- Endologix (ELGX) Tops Q3 EPS by 1c; Guides In-line
- Endologix Reports 47% Third Quarter 2009 Revenue Growth
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
Endologix Inc. (NASDAQ: ELGX) reports Q3 EPS of $0.00, 1 cent better than the analyst estimate of ($0.01). Revenue for the quarter was $13.8 million, which compares to the estimate of $13.10 million.
The Company is re-affirming its full year 2009 guidance of revenue in the range of $51 to $53 million vs. $52.15 million consensus.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
